Semper Paratus Acquisition Unveils Major Corporate Restructuring Plans

Semper Paratus Acquisition Corporation Class A (LGST) has released an update to notify the public and investors about a regulation fd disclosure.

Semper Paratus Acquisition Corporation announced the filing of a Prospectus Supplement to its definitive proxy statement/prospectus, related to an upcoming extraordinary general meeting of shareholders to vote on a Business Combination. This entails Semper Paratus’ de-registration from the Cayman Islands, redomiciliation to Delaware, renaming to Tevogen Bio Holdings Inc., and its subsidiary merging with Tevogen Bio. The parties also plan to list the new company’s stock on The Nasdaq Stock Market, a change from the previously disclosed NYSE American.

For further insights into LGST stock, check out TipRanks’ Stock Analysis page.